SRGN and cancer: Then, a pan-cancer differential expression analysis was performed, and we found that genes such as CXCL13, ITM2A, NR3C1, SRGN, COTL1, and PDCD1 were significantly up-regulated in SC-2 cells compared with other cells in at least five cancer types, but not in SC-10 cells (Figure 4E).